-transparent.png){kind=logo}
Different chronotropic and inotropic effects of EMD 57033 and EMD 53998, Ca2+ sensitizers, on isolated, blood-perfused dog heart preparations. 1998
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
Department of Pharmacology, Shinshu University School of Medicine, Matsumoto, Japan.
To investigate whether a Ca2+ sensitizer increases sinus rate, we studied the effects of racemic thiadiazinone, EMD 53998 (a Ca2+ sensitizer with phosphodiesterase inhibitory action) and its (+)-enantiomer EMD 57033 (a relatively pure Ca2+ sensitizer) on isolated, blood-perfused spontaneously beating right atria and paced left ventricles of the dogs. EMD 53998 increased sinus rate dose-dependently, but EMD 57033 did not. Both substances increased atrial and ventricular contractile force. Propranolol did not affect the responses to each substance. These results suggest that the Ca2+ sensitizing action induced by EMD 57033 does not affect pacemaker currents directly.
Related Publications
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
July 1976,
European journal of pharmacology,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
October 1989,
Japanese journal of pharmacology,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
August 1995,
The American journal of physiology,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
February 2000,
Japanese journal of pharmacology,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
January 1980,
Japanese heart journal,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
January 2016,
The Journal of toxicological sciences,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
October 1980,
European journal of pharmacology,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
May 1989,
Japanese heart journal,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
January 1977,
Archives internationales de pharmacodynamie et de therapie,
M Lakhe, and
Y Furukawa, and
T Yonezawa, and
M Hirose, and
Y Nagashima, and
Y Miyashita, and
S Chiba
January 1978,
Clinical and experimental pharmacology & physiology,
